标题
Biomarker GDF-15 in cardiology
作者
关键词
-
出版物
Vnitrni Lekarstvi
Volume 67, Issue 3, Pages e11-e14
出版商
Solen s.r.o.
发表日期
2021-05-27
DOI
10.36290/vnl.2021.045
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
- (2020) Peter Jirak et al. Journal of Clinical Medicine
- Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48
- (2019) David Douglas Berg et al. CIRCULATION
- The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
- (2019) Bernadet T. Santema et al. Clinical Research in Cardiology
- Circulating Levels of Biomarkers of Cerebral Injury in Patients with Atrial Fibrillation
- (2019) Oxana Galenko et al. AMERICAN JOURNAL OF CARDIOLOGY
- Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial
- (2018) Nadia Bouabdallaoui et al. EUROPEAN JOURNAL OF HEART FAILURE
- A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
- (2017) Ziad Hijazi et al. EUROPEAN HEART JOURNAL
- GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
- (2017) Shannon E Mullican et al. NATURE MEDICINE
- Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores
- (2017) Vanessa Roldán et al. THROMBOSIS AND HAEMOSTASIS
- Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial
- (2017) María Esteve-Pastor et al. THROMBOSIS AND HAEMOSTASIS
- Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure
- (2017) Abhinav Sharma et al. JACC-Heart Failure
- Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study
- (2016) Lars Wallentin et al. LANCET
- The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
- (2016) Ziad Hijazi et al. LANCET
- Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study
- (2015) Gad Cotter et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of Left Ventricular Assist Device Support on Biomarkers of Cardiovascular Stress, Fibrosis, Fluid Homeostasis, Inflammation, and Renal Injury
- (2015) Tariq Ahmad et al. JACC-Heart Failure
- Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
- (2014) Abdelkader Kahli et al. PLoS One
- Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
- (2013) Lars Wallentin et al. CIRCULATION
- Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization
- (2013) Lars Wallentin et al. CIRCULATION
- Incremental Prognostic Value of Biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) Score and High-Sensitivity Cardiac Troponin T in Non-ST-Elevation Acute Coronary Syndrome
- (2013) C. Widera et al. CLINICAL CHEMISTRY
- Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support
- (2012) Sjoukje I. Lok et al. EUROPEAN JOURNAL OF HEART FAILURE
- Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome
- (2010) Marc P. Bonaca et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure
- (2010) Inder S. Anand et al. CIRCULATION
- Response of growth differentiation factor-15 to percutaneous coronary intervention and regular exercise training
- (2010) Peter Scott Munk et al. SCANDINAVIAN CARDIOVASCULAR JOURNAL
- Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
- (2009) P. W.X. Foley et al. EUROPEAN HEART JOURNAL
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started